SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-017857
Filing Date
2023-03-06
Accepted
2023-03-06 17:29:25
Documents
4
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a0323_adialpharma.htm DEF 14A 413499
2 GRAPHIC tadial_logo.jpg GRAPHIC 138070
3 GRAPHIC tproxy_001.jpg GRAPHIC 1061135
4 GRAPHIC tproxy_002.jpg GRAPHIC 528490
  Complete submission text file 0001213900-23-017857.txt   2795163
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38323 | Film No.: 23710083
SIC: 2834 Pharmaceutical Preparations